Lung-surfactant-meconium interaction: in vitro study in bulk and at the air-solution interface

Area of Science:

• Biochemistry
• Pulmonary Physiology
• Surface Chemistry

Background:

• Lung surfactants (LSs) are vital for breathing, forming a monolayer at the air-solution interface to reduce surface tension.
• LS function can be impaired by various agents, including tobacco smoke and meconium, a neonatal risk factor.

Purpose of the Study:

• To investigate the in vitro interactions between lung surfactants and meconium, or their artificial analogues.
• To elucidate the mechanism by which taurocholic acid (TA), a bile component, affects surfactant structure and function.

Main Methods:

• Studied interactions between modified porcine LSs (Curosurf) and meconium, and their artificial analogues (phospholipids and TA).
• Examined interactions in bulk solution and at the air-water interface to simulate pre- and postnatal conditions.
• Utilized artificial analogues to reliably represent natural system effects.

Main Results:

• Artificial analogues effectively mimicked the interactions observed in the natural system.
• TA significantly altered the structure of both interfacial monolayers and surfactant aggregates in solution.
• TA's stereoselective penetration into surfactant structures likely disrupts monolayer and vesicle integrity.

Conclusions:

• Taurocholic acid is identified as a potent disruptor of lung surfactant structure.
• The findings suggest a mechanism for LS poisoning involving TA's interaction with surfactant monolayers and aggregates.
• Understanding these interactions is crucial for addressing neonatal respiratory distress associated with meconium aspiration.